Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Ancilia Biosciences Logo
Ancilia Biosciences Growth Score
88
CB Rank
17337
Heat Score
73
Ancilia Biosciences offers bacterial therapeutics that address the microbiome's viral components.
Founded
obfuscation
PrivateVenture - Series Unknown New York, New York, United States1-10 www.anciliabio.com
Biotechnology
Health Care
Life Science
Overview

Ancilia Biosciences
Total Funding
obfuscation
Growth Score
88
Heat Score
73

Total Funding
obfuscation
obfuscation
Venture - Series Unknown raised
obfuscation
Growth Score88
-1 pts
in past quarter
Heat Score 73
3 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Ancilia Biosciences

CB Rank
17337
Ancilia Biosciences offers bacterial therapeutics that address the microbiome's viral components.
Founded
obfuscation
PrivateVenture - Series Unknown New York, New York, United States1-10 www.anciliabio.com
Biotechnology
Health Care
Life Science

Funding Rounds

Venture - Series Unknown
OBF
in
obfuscation
Venture - Series Unknown
OBF
in
obfuscation
Debt Financing
OBF
in
obfuscation

Key People

Details

Legal Name Ancilia, Inc.
Operating Status Active
Company Type For Profit
Founders  Alexandra Sakatos, Matthew Cummings
About the Company
Ancilia Biosciences develops engineered bacterial therapies to treat diseases linked to the microbiome. It provides and develops novel bacterial therapies that target the viral components of the microbiome to address chronic diseases across immunology and oncology indications.
Contact Email info@anciliabio.com
Diversity Spotlight 
Women Founded
Predictions & Insights

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Awards

Products & Services

CoVE™ Computational Virome Engine
A platform that computationally identifies and characterizes the virome and designs solutions to counteract specific destructive viruses.
EPIC™ Enhancing Phage Immunity with CRISPR
A platform that uses CRISPR to develop live bacterial therapeutics and products with immunity against viruses that infect bacteria.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 5
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Venture Round - Ancilia Biosciences Logo
Venture Round - Ancilia Biosciences
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Ancilia Biosciences Logo
Venture Round - Ancilia Biosciences
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Ancilia Biosciences Logo
Venture Round - Ancilia Biosciences
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Ancilia Biosciences Logo
Venture Round - Ancilia Biosciences
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Ancilia Biosciences Logo
Venture Round - Ancilia Biosciences
—
obfuscation
— Venture - Series Unknown

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 5
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Venture Round - Ancilia Biosciences Logo
Venture Round - Ancilia Biosciences
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Ancilia Biosciences Logo
Venture Round - Ancilia Biosciences
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Ancilia Biosciences Logo
Venture Round - Ancilia Biosciences
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Ancilia Biosciences Logo
Venture Round - Ancilia Biosciences
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Ancilia Biosciences Logo
Venture Round - Ancilia Biosciences
—
obfuscation
— Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
Spacecadet Ventures Logo
Spacecadet Ventures
—
Venture Round - Ancilia Biosciences Logo
Venture Round - Ancilia Biosciences
—
Spacecadet Ventures Logo
Spacecadet Ventures
—
Venture Round - Ancilia Biosciences Logo
Venture Round - Ancilia Biosciences
—
Spacecadet Ventures Logo
Spacecadet Ventures
—
Venture Round - Ancilia Biosciences Logo
Venture Round - Ancilia Biosciences
—
Spacecadet Ventures Logo
Spacecadet Ventures
—
Venture Round - Ancilia Biosciences Logo
Venture Round - Ancilia Biosciences
—
Spacecadet Ventures Logo
Spacecadet Ventures
—
Venture Round - Ancilia Biosciences Logo
Venture Round - Ancilia Biosciences
—
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 2 Board Members and Advisors 2 Contacts 6

Employee Profiles

Board Members and Advisors

News

News and Press

News•Dec 5, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Aug 28, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jul 25, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jul 18, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

244
-18.67%
 in past month

IT Spend

$100.2KThis year, Ancilia Biosciences is projected to spend $100.2K on IT, according to Aberdeen.

Active Website Tech Count

2Ancilia Biosciences is actively using 2 technologies for its website, according to BuiltWith. These include CommonCrawl Top 5m.

Total IP

3The intellectual property of Ancilia Biosciences includes 3 registered patents primarily in the 'Computing; Calculating' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Ancilia Biosciences's headquarters? Ancilia Biosciences is located in New York, New York, United States.Who invested in Ancilia Biosciences? Ancilia Biosciences has 8 investors including Spacecadet Ventures and  PsyMed Ventures.When was the last funding round for Ancilia Biosciences? Ancilia Biosciences closed its last funding round on
obfuscation
from a Venture - Series Unknown round.Who are Ancilia Biosciences's competitors? Alternatives and possible competitors to Ancilia Biosciences may include Tenaya Therapeutics, HAYA Therapeutics, and  Capricor Therapeutics.How much funding has Ancilia Biosciences raised to date? Ancilia Biosciences has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(3ff49e4 1)
|